Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Status:
Active, not recruiting

Trial end date:
2021-10-29

Target enrollment:

Participant gender:

The study was performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

Phase 3

Bayer